Breaking news

Government Commitment To €125 Million For Crete-Cyprus Electrical Link Raises Fiscal And Geopolitical Concerns

Mounting Financial And Legal Uncertainties

A recent official announcement by ALMA has spotlighted the contentious financial and geopolitical implications of the Crete-Cyprus electrical interconnection. Amid intense pressure on the Cyprus Regulatory Authority of Energy (RAEK), the body responsible for the project’s implementation is currently seeking recognition of expenses nearing €300 million. This financial assessment, pivotal to the government’s eventual commitment, would initially trigger an obligation to pay €125 million—distributed over five years as per the September 2024 bilateral agreement between Cyprus and Greece.

Discrepancies In Government Accountability

Beyond the fiscal complexities, the process is mired in questions about governmental governance and accountability. Criticism has emerged over the apparent reliance on disputed interpretations of data provided by ADEME and the absence of independent studies. The decision has further stirred controversy as dissent exists among senior officials—evidenced by discord between the Finance and Energy Ministers—and even extends to the President, who has refrained from accepting responsibility for such a significant governmental commitment. Such internal disagreements cast doubts on the capacity of the administration to deliver a robust and responsible long-term strategy.

Historical Precedents And The Call For Decisive Action

The current predicament echoes earlier decisions made by the Anastasiades-DISY government, which advanced the project without adequately addressing emerging technical challenges, economic sustainability, and the inherent geopolitical risks—including potential disruptions by Turkey. Alongside these issues, investigations by the European Public Prosecutor are examining past transactions and the dubious outsourcing of the project to a company deemed unsuitable to handle such a large-scale endeavor. These factors have compounded public concern over the future liabilities faced by taxpayers should the project be abandoned.

Conclusion: Necessity For Clear, Prompt Decision-Making

In light of the escalating financial exposure and geopolitical complexities, it is imperative that both the government and RAEK adopt a transparent, comprehensive approach to determining the fate of the Crete-Cyprus interconnection. Delay risks not only increasing the potential compensation claims but also undermining investor confidence and the strategic ties with both Greece and the European Union. Ultimately, a decision founded on rigorous, independent analysis will be crucial in safeguarding national interests and maintaining fiscal responsibility.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

eCredo
Uol
Aretilaw firm
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter